A detailed history of Kapstone Financial Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kapstone Financial Advisors LLC holds 9,896 shares of MRK stock, worth $981,386. This represents 0.68% of its overall portfolio holdings.

Number of Shares
9,896
Previous 9,896 -0.0%
Holding current value
$981,386
Previous $1.23 Billion 8.17%
% of portfolio
0.68%
Previous 0.8%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $31,816 - $34,170
257 Added 2.67%
9,896 $1.23 Billion
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $3,283 - $3,826
-29 Reduced 0.3%
9,639 $1.27 Billion
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $34,161 - $37,175
341 Added 3.66%
9,668 $1.16 Billion
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $6,951 - $7,576
64 Added 0.69%
9,327 $982 Million
Q4 2022

Feb 15, 2023

BUY
$87.44 - $112.11 $809,956 - $1.04 Million
9,263 New
9,263 $958 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kapstone Financial Advisors LLC Portfolio

Follow Kapstone Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kapstone Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kapstone Financial Advisors LLC with notifications on news.